TOCILIZUMAB (TCZ) MONOTHERAPY IS SUPERIOR TO ADALIMUMAB (ADA) MONOTHERAPY IN REDUCING DISEASE ACTIVITY IN PATIENTS WITH RHEUMATOID ARTHRITIS (RA): 24-WEEK DATA FROM THE PHASE 4 ADACTA TRIAL

被引：20

作者：

Gabay, C. ^{[1
]}

Emery, P. ^{[2
]}

van Vollenhoven, R. ^{[3
]}

Dikranian, A. ^{[4
]}

Alten, R. ^{[5
]}

Klearman, M. ^{[6
]}

Musselman, D. ^{[6
]}

Agarwal, S. ^{[6
]}

Green, J. ^{[7
]}

Kavanaugh, A. ^{[8
]}

机构：

[1] Univ Hosp Geneva, Geneva, Switzerland

[2] Univ Leeds, Leeds, W Yorkshire, England

[3] Karolinska Inst, Stockholm, Sweden

[4] San Diego Arthrit Med Clin, San Diego, CA USA

[5] Univ Berlin, Berlin, Germany

[6] Genentech Inc, San Francisco, CA 94080 USA

[7] Roche, Welwyn Garden City, England

[8] Univ Calif San Diego, San Diego, CA 92103 USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 71卷

关键词：

D O I：

10.1136/annrheumdis-2012-eular.1963

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：152 / 152

页数：1

共 5 条

[1]

[Anonymous], 2011, DOUGADOS ARTHRITIS S, V63, pS1032

[2]

[Anonymous], 2011, WEINBLATT ARTHRITI S, V63, pS864

[3] Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study [J].

Jones, G. ;

Sebba, A. ;

Gu, J. ;

Lowenstein, M. B. ;

Calvo, A. ;

Gomez-Reino, J. J. ;

Siri, D. A. ;

Tomsic, M. ;

Alecock, E. ;

Woodworth, T. ;

Genovese, M. C. .

ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (01) :88-96

[4] Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register [J].

Soliman, Moetaza M. ;

Ashcroft, Darren M. ;

Watson, Kath D. ;

Lunt, Mark ;

Symmons, Deborah P. M. ;

Hyrich, Kimme L. .

ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (04) :583-589

[5]

Yazici Y, 2008, BULL HOSP JT DIS, V66, P77

← 1 →